Sernova Biotherapeutics (OTCMKTS:SEOVF) Stock Price Crosses Below Fifty Day Moving Average – Here’s Why

Sernova Biotherapeutics Inc. (OTCMKTS:SEOVF)’s stock price crossed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $0.10 and traded as low as $0.0792. Sernova Biotherapeutics shares last traded at $0.0792, with a volume of 420 shares changing hands.

Sernova Biotherapeutics Stock Down 1.7%

The firm has a market capitalization of $29.91 million, a price-to-earnings ratio of -1.98 and a beta of 0.84. The stock’s fifty day moving average is $0.10 and its two-hundred day moving average is $0.11.

Sernova Biotherapeutics (OTCMKTS:SEOVF) last posted its quarterly earnings results on Thursday, June 11th. The company reported ($0.01) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.01).

Sernova Biotherapeutics Company Profile

Sernova Biotherapeutics is a clinical?stage biotechnology company focused on developing and commercializing cell?based therapeutic technologies for patients with chronic and life?threatening diseases. Headquartered in London, Ontario, Canada, the firm is advancing an implantable device platform designed to support the long-term survival and function of therapeutic cells. The company’s lead product candidate, known as the Cell Pouch System, is engineered to create a vascularized environment in which transplanted cells can thrive, with an initial emphasis on treating patients with type 1 diabetes.

In its core program, Sernova has initiated a Phase I/II clinical trial evaluating the safety and efficacy of the Cell Pouch System in individuals with type 1 diabetes who require islet cell transplantation.